Similar articles

• Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.

  Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Chopra HK, et al. J Med. 1988;19(2):89-107. J Med. 1988. PMID: 3049876 Review.
• [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].

  Gómez Reyes D, Rojas Hidalgo E. Gómez Reyes D, et al. Rev Clin Esp. 1988 Jan;182(1):3-6. Rev Clin Esp. 1988. PMID: 3375512 Spanish. No abstract available.
• [Training by walking and drug therapy of peripheral arterial occlusive disease].

  Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G. Kiesewetter H, et al. Vasa Suppl. 1987;20:384-7. Vasa Suppl. 1987. PMID: 3321495 Clinical Trial. German. No abstract available.
• [Treatment of arterial diseases with trental 400. Results of a double-blind study].

  Völker D. Völker D. Med Welt. 1978 Aug 11;29(32):1244-7. Med Welt. 1978. PMID: 672594 Clinical Trial. German. No abstract available.
• Pentoxifylline -- a biomedical profile.

  Müller R. Müller R. J Med. 1979;10(5):307-29. J Med. 1979. PMID: 393789 Review.